These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6543399)

  • 21. Lesions of ventral tegmental dopamine neurons delay the development of tolerance to morphine catalepsy.
    Hand TH; Franklin KB
    Neurosci Lett; 1985 Apr; 55(3):367-70. PubMed ID: 4040227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of morphinan drugs on haloperidol-induced catalepsy in rats: a comparative study with an N-methyl-D-aspartate antagonist.
    Scotti de Carolis A; Popoli P; Pezzola A; Sagratella S
    Arch Int Pharmacodyn Ther; 1991; 310():132-41. PubMed ID: 1685312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of relative intrinsic activity of mu-opioid analgesics in vivo by using beta-funaltrexamine.
    Adams JU; Paronis CA; Holtzman SG
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1027-32. PubMed ID: 2175793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of morphine-induced catalepsy, lethality, and analgesia by a benzodiazepine receptor agonist midazolam in the rat.
    Rattan AK; Sribanditmongkol P
    Pharmacol Biochem Behav; 1994 Jun; 48(2):357-61. PubMed ID: 8090801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The determination of the relative configuration of morphine, levorphanol and laevophenazocine by stereoselective adsorbents.
    BECKETT AH; ANDERSON P
    J Pharm Pharmacol; 1960 Dec; 12(Suppl)():228-36. PubMed ID: 13688527
    [No Abstract]   [Full Text] [Related]  

  • 26. REM sleep deprivation antagonizes morphine-induced akinesia and catalepsy.
    Ukponmwan OE; v d Poel-Heisterkamp AL; Dzoljic MR
    Sleep; 1986; 9(3):415-22. PubMed ID: 3020674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of H2 receptor blockade upon hypothermic, cataleptogenic and antinociceptive action of prostacyclin (PGI)2 administered into the lateral rat brain ventricle.
    Brus R; Krzemiński T; Juraszczyk Z; Kurocok A
    Biomed Biochim Acta; 1985; 44(4):637-44. PubMed ID: 2862862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. QUANTITATIVE STUDIES OF THE ANTAGONISM BY NALORPHINE OF SOME OF THE ACTIONS OF MORPHINE-LIKE ANALGESIC DRUGS.
    COX BM; WEINSTOCK M
    Br J Pharmacol Chemother; 1964 Apr; 22(2):289-300. PubMed ID: 14190464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypokinesia in mice and catalepsy in rats elicited by morphine associated with antidopaminergic agents, including atypical neuroleptics.
    Barghon R; Protais P; Colboc O; Costentin J
    Neurosci Lett; 1981 Nov; 27(1):69-73. PubMed ID: 6120489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative analgesic potency of intramuscular heroin and morphine in cancer patients with postoperative pain and chronic pain due to cancer.
    Kaiko RF; Wallenstein SL; Rogers A; Grabinski P; Houde RW
    NIDA Res Monogr; 1981 Feb; 34():213-9. PubMed ID: 6783935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antagonism of morphine-induced catalepsy by L-prolyl-L-leucyl-glycinamide.
    Chiu S; Mishra RK
    Eur J Pharmacol; 1979 Jan; 53(2):119-25. PubMed ID: 32058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the discriminative effects of morphine in the rat.
    Shannon HE; Holtzman SG
    J Pharmacol Exp Ther; 1976 Jul; 198(1):54-65. PubMed ID: 6794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of opioid cataleptic response by cortical frontal deafferentation or intrastriatal injection of NMDA-receptor antagonists.
    Consolo S; Forloni G; Ladinsky H; Palazzi E
    Brain Res; 1988 May; 449(1-2):97-103. PubMed ID: 2899450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissociable effects of ultralow-dose naltrexone on tolerance to the antinociceptive and cataleptic effects of morphine.
    Tuerke KJ; Beninger RJ; Paquette JJ; Olmstead MC
    Behav Pharmacol; 2011 Sep; 22(5-6):558-63. PubMed ID: 21555938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catalepsy induced by combinations of ketamine and morphine: potentiation, antagonism, tolerance and cross-tolerance in the rat.
    Hance AJ; Winters WD; Quam DD; Benthuysen JL; Cadd GG
    Neuropharmacology; 1989 Feb; 28(2):109-16. PubMed ID: 2716967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The NMDA receptor antagonist MK-801 increases morphine catalepsy and lethality.
    Trujillo KA; Akil H
    Pharmacol Biochem Behav; 1991 Mar; 38(3):673-5. PubMed ID: 1829839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolism and disposition of 3,6-dibutanoylmorphine in rat brain.
    Tasker RA; Nakatsu K
    Can J Physiol Pharmacol; 1986 Sep; 64(9):1160-3. PubMed ID: 3779514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bilateral injection of kainic acid into the rat striatum potentiates morphine, arecoline and pilocarpine but not haloperidol catalepsy.
    Turski W; Czuczwar SJ; Turski L; Kleinrok Z
    Methods Find Exp Clin Pharmacol; 1982; 4(5):287-91. PubMed ID: 6889661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cataleptogenic effect of haloperidol, chlorpromazine and morphine in developing rats.
    Brus R; Krzemiński T; Piguła J
    Pol J Pharmacol Pharm; 1983; 35(5):377-82. PubMed ID: 6686676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. mu Opioid receptor-mediated G-protein activation by heroin metabolites: evidence for greater efficacy of 6-monoacetylmorphine compared with morphine.
    Selley DE; Cao CC; Sexton T; Schwegel JA; Martin TJ; Childers SR
    Biochem Pharmacol; 2001 Aug; 62(4):447-55. PubMed ID: 11448454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.